ImmunoPET in oncology

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Sep-Oct;41(5):332-339. doi: 10.1016/j.remnie.2022.08.001. Epub 2022 Aug 10.

Abstract

Due to increase of immunotherapy in oncology, it is essential to have a biological characterization of tumors. Knowing which antigens are expressed both on the surface of the tumor cell and at tumor microenvironment in order to predict the tretment response different therapeutic antibodies, has become a need. ImmunoPET is a non-invasive diagnostic imaging tool that combines the high specificity of antibodies against antigens with the high sensitivity, resolution and quantification capacity of PET imaging. With ImmunoPET we obtain a virtual biopsy of tumors, it has a big present and future in preclinical-clinical research, being already a reality in predicting and monitoring the response to treatments with monoclonal antibodies, allowing a selection of patients and therapies reaching a personalized medicine contributing to improve clinical decisions.

Keywords: ImmunoPET; Immunotherapy; InmunoPET; Inmunoterapia; Oncology; Oncología.

MeSH terms

  • Antibodies*
  • Humans
  • Immunotherapy
  • Positron-Emission Tomography* / methods

Substances

  • Antibodies